Prosecution Insights
Last updated: April 19, 2026

Pmv Pharmaceuticals Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18582046 DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION SAEED, KAMAL A 1626 Non-Final OA Feb 20, 2024
18368467 Heterocycles as WIP1 Inhibitors VALENROD, YEVGENY 1628 Non-Final OA Sep 14, 2023
18351108 MDM2 INHIBITORS AND USES THEREOF JOHNSON, CHRISTOPHER LINDSAY 1691 Non-Final OA Jul 12, 2023

Managing Pmv Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month